[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fblGmxnxM2to5a2oaT_ELNQm8UPojDr5Gkbe4KFF7D2w":8,"$fWIWYvQAiD2kdHS_57OBA0EWLwodfTUhk05Iew9X2tJg":55,"$fRshmEr3tHFlJlbDeMDxTEzYirIMyemLhAMVtvq0wjcI":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},76694,871403,[],"https://ystcdn.venuertc.com/venue/app/37625/2025-12-11/938d3d96-c361-4b34-835d-0bd8e72afec3.png","史根兵","上海电力医院","骨科","副主任医师",18,0,"药品实用指南：腺泡状软组织肉瘤治疗中常用药物的安全使用要点","","https://ystcdn.venuertc.com/venue/AI/337c74d3-4ff0-4bea-9412-dbbd39d687be.jpg","\u003Cdiv class=\"softsarcoma-container\">\n  \u003Ch1 id=\"material_title\" class=\"softsarcoma-main-title\">药品实用指南：腺泡状软组织肉瘤治疗中常用药物的安全使用要点\u003C/h1>\n  \n  \u003Csection class=\"softsarcoma-section softsarcoma-bg01\">\n    \u003Ch2 class=\"softsarcoma-subtitle\">🕒 01. 服用时间和方法：什么时候、怎么吃？\u003C/h2>\n    \u003Cdiv class=\"softsarcoma-block\">\n      \u003Cp>\n        不同治疗腺泡状软组织肉瘤的药物，服用时间和方法有所差异。我们简单举例三类常用药物，分别说明：\n      \u003C/p>\n      \u003Cul class=\"softsarcoma-list\">\n        \u003Cli>\n          \u003Cstrong>化疗药（如多柔比星注射液）：\u003C/strong>\n          正确做法：静脉注射给药。通常于医院由专业医护人员操作，严格按照规定的周期和剂量执行。需要配合大量液体补液，缓慢注射以减少刺激。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>靶向药物（如帕唑帕尼片）：\u003C/strong>\n          正确做法：每日一次，空腹服用（餐前至少1小时或餐后2小时），用温水整片吞服。不推荐咀嚼或掰碎。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>辅助用药（如地塞米松片缓解副作用）：\u003C/strong>\n          正确做法：遵医嘱，每日1-2次，餐后服用，可减少胃肠刺激。用水送服即可。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"softsarcoma-tip\">\n        特别提醒：任何药物首次使用前都应确认名称和规格，避免误服。家庭服药务必记录用药时间，形成规律，减少漏服。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"softsarcoma-section softsarcoma-bg02\">\n    \u003Ch2 class=\"softsarcoma-subtitle\">💊 02. 剂型与服药技巧：片、注射、口服液怎样区分用？\u003C/h2>\n    \u003Cdiv class=\"softsarcoma-block\">\n      \u003Cul class=\"softsarcoma-list\">\n        \u003Cli>\n          \u003Cstrong>注射剂型：\u003C/strong>\n          常见于化疗药如多柔比星，需在医院静脉注射，严禁自行操作。正确做法：配合医药工作人员，确保药液溶解均匀，无沉淀或异常颜色。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>片剂：\u003C/strong>\n          靶向药（如帕唑帕尼）、辅助药（如地塞米松）多为片剂。正确做法：整片吞服，使用温水，不要掰碎或咀嚼，除非说明书允许。胶囊不能拆开倒药粉服用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>口服溶液：\u003C/strong>\n          有些辅助药为口服液体，服用时需使用专用量杯量取，避免随意倒取，药量更准确。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"softsarcoma-tip\">\n        正确做法：所有剂型药品均需注意规格（mg数），尤其是化疗药，剂量差错危害极大。口服药后建议喝200ml左右清水。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"softsarcoma-section softsarcoma-bg03\">\n    \u003Ch2 class=\"softsarcoma-subtitle\">⚠️ 03. 药物相互作用：哪些药物不能一起服？\u003C/h2>\n    \u003Cdiv class=\"softsarcoma-block\">\n      \u003Cp>\n        药物联用是治疗中的常见难题。以帕唑帕尼为例，和其他药物的相互作用需高度警惕：\n      \u003C/p>\n      \u003Cul class=\"softsarcoma-list\">\n        \u003Cli>\n          \u003Cstrong>PPI类抑酸药（如奥美拉唑）：\u003C/strong>\n          可能显著降低帕唑帕尼的血药浓度，并影响其疗效。正确做法：两药至少间隔2小时以上，或选用其他不影响胃酸的药物，如抗酸剂。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>抗真菌药（如酮康唑）：\u003C/strong>\n          可能增加靶向药血药浓度，带来毒性风险。正确做法：严格遵医嘱，避免自行叠加。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>华法林等抗凝药：\u003C/strong>\n          靶向药与华法林合用会增强出血风险。用药中需定期检测凝血指标。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"softsarcoma-tip\">\n        需要注意：遇到需要长期合用多种药，需要医生逐一排查药物相互作用。千万不可自行叠加补品、草药或保健品。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"softsarcoma-section softsarcoma-bg04\">\n    \u003Ch2 class=\"softsarcoma-subtitle\">👨‍⚕️ 04. 特殊人群用药调整：不同体质有区别吗？\u003C/h2>\n    \u003Cdiv class=\"softsarcoma-block\">\n      \u003Cul class=\"softsarcoma-list\">\n        \u003Cli>\n          \u003Cstrong>老年人：\u003C/strong>\n          正确做法：剂量往需从低剂量起步，并严密监测心、肝、肾功能。剂量调整要比青年更加谨慎。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>儿童：\u003C/strong>\n          少见用药，但如必须，则需根据体重精准计算剂量，严禁使用成人剂型掰分。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>孕妇和哺乳期妇女：\u003C/strong>\n          多数化疗/靶向药为孕妇绝对禁用，只有医生评估利大于弊时极特殊考虑，且需停药1年以上再备孕。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肝、肾功能不全患者：\u003C/strong>\n          部分药物（如帕唑帕尼）需减量或者禁止使用。具体参考说明书或专业药师意见。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"softsarcoma-tip\">\n        关键点：用药涉及特殊人群时，必须提前让医生知道所有既往病史和药物过敏情况，既要安全又要有效。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"softsarcoma-section softsarcoma-bg05\">\n    \u003Ch2 class=\"softsarcoma-subtitle\">😬 05. 常见不良反应：哪些最常见？如何处理？\u003C/h2>\n    \u003Cdiv class=\"softsarcoma-block\">\n      \u003Cul class=\"softsarcoma-list\">\n        \u003Cli>\n          \u003Cstrong>化疗类药物：\u003C/strong>\n          多柔比星等常见恶心、脱发、轻度发热。正确做法：服药当日多饮水、进食清淡，联合使用止吐剂预防。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>靶向类药物：\u003C/strong>\n          帕唑帕尼等可引起高血压、腹泻、疲劳。正确做法：发现腹泻时加服蒙脱石散，出现高血压及时检测血压并告知医生。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>辅助用药：\u003C/strong>\n          地塞米松易导致食欲增加、水肿。剂量逐渐减量、注意监测体重与血糖。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"softsarcoma-tip\">\n        重要提醒：多数不良反应可预防，对症支持处理为主。出现持续性呕吐、皮肤变化、黄疸、不可控制的血压等情况，该立刻就医。\n      \u003C/div>\n      \u003Cdiv class=\"softsarcoma-data\">\n        \u003Cem>临床资料：\u003C/em>\n        一项对帕唑帕尼相关研究显示，20%-30%患者用药后有腹泻，10%以上有高血压和肝功能异常（Sleijfer et al., 2009）。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"softsarcoma-section softsarcoma-bg06\">\n    \u003Ch2 class=\"softsarcoma-subtitle\">🧊 06. 储存条件和有效期：药怎么放才安全不失效？\u003C/h2>\n    \u003Cdiv class=\"softsarcoma-block\">\n      \u003Cul class=\"softsarcoma-list\">\n        \u003Cli>\n          \u003Cstrong>化疗药品：\u003C/strong>\n          需避光、2-8°C冷藏。开封后24小时内必须用完，不可冷冻或暴露在高温环境下。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>靶向药：\u003C/strong>\n          常温储存，避光、密封，远离儿童。开盖后四周内用完，过期丢弃。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>辅助药：\u003C/strong>\n          片剂类宜干燥处避光保存，开封后瓶口拧紧。避免浴室等潮湿环境。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"softsarcoma-tip\">\n        特别提醒：切勿将药品和食品存放一起，也要远离酒精、腐蚀性化学品。不认识的药品、包装破损的药务必不要使用。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"softsarcoma-section softsarcoma-bg07\">\n    \u003Ch2 class=\"softsarcoma-subtitle\">⏰ 07. 漏服与过量：忘记或多吃怎么办？\u003C/h2>\n    \u003Cdiv class=\"softsarcoma-block\">\n      \u003Cul class=\"softsarcoma-list\">\n        \u003Cli>\n          \u003Cstrong>漏服：\u003C/strong>\n          如果距离下次服药还有4小时以上，立即补服；如果接近下次服药时间，跳过该次，按原计划继续。不建议一次服用双倍剂量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>过量：\u003C/strong>\n          发生多吃药物时，要立刻停止继续服药，并立即联系医生或前往急诊室。不要自行诱导呕吐。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"softsarcoma-tip\">\n        需要注意：服药最好提前设置闹钟提醒或使用药盒区分早晚药物。过量用药症状隐匿时也需观察，切勿轻视。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"softsarcoma-section softsarcoma-bg08\">\n    \u003Ch2 class=\"softsarcoma-subtitle\">🔎 用药案例分享\u003C/h2>\n    \u003Cdiv class=\"softsarcoma-block\">\n      \u003Cul class=\"softsarcoma-list\">\n        \u003Cli>\n          一位24岁男性患者在使用多柔比星时，因未注意间隔期，导致轻度骨髓抑制，后经调整周期并强化监测后安全完成疗程。\n        \u003C/li>\n        \u003Cli>\n          临床上有患者联合使用帕唑帕尼与奥美拉唑后，靶向药效果降低，停用抑酸药后药效恢复。\n        \u003C/li>\n        \u003Cli>\n          有患者服用地塞米松后出现体重增长，后由专业药师建议调整饮食和剂量渐减后症状缓解。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"softsarcoma-section softsarcoma-bg09\">\n    \u003Ch2 class=\"softsarcoma-subtitle\">🌟 结语：安全合理用药，疗效才更佳\u003C/h2>\n    \u003Cdiv class=\"softsarcoma-block\">\n      \u003Cp>\n        治疗腺泡状软组织肉瘤常用药物种类多、作用机制复杂，每个关键细节都决定安全和疗效。无论是服用时间、剂量、药物相互作用、特殊人群剂量调整，还是储存条件和漏服处理，所有细节串联起安全用药的每一环。\n      \u003C/p>\n      \u003Cp>\n        \u003Cstrong>要点回顾：\u003C/strong>用药过程中，患者要积极了解说明书并与医生、药师配合，发现异常及时停药就医。在多药联用和用药周期较长时，特别注意药物互相影响和累计毒性。最后，勤做记录，定期复查，提高家庭药品管理意识，是安全用药的最好保障。\n      \u003C/p>\n      \u003Cp>\n        如对药物的具体使用仍有疑问，请实时向专业医务人员咨询，再慎重用药。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"softsarcoma-section softsarcoma-reference\">\n    \u003Ch2 class=\"softsarcoma-subtitle\">📚 参考文献\u003C/h2>\n    \u003Cul class=\"softsarcoma-list softsarcoma-ref-list\">\n      \u003Cli>\n        Sleijfer, S., Ray-Coquard, I., Papai, Z., Le Cesne, A., Scurr, M., Schöffski, P., ... & van der Graaf, W. T. (2009).\n        Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study.\n        \u003Cem>The Lancet Oncology, 10\u003C/em>(8), 722-728.\n      \u003C/li>\n      \u003Cli>\n        van der Graaf, W. T., Blay, J. Y., Chawla, S. P., Kim, D. W., Bui-Nguyen, B., Casali, P. G., ... & Judson, I. (2012).\n        Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.\n        \u003Cem>The Lancet, 379\u003C/em>(9829), 1879-1886.\n      \u003C/li>\n      \u003Cli>\n        Brahmer, J. R., & Lacchetti, C. (2018).\n        Use of chemotherapy and targeted agents in rare soft tissue sarcomas.\n        \u003Cem>American Society of Clinical Oncology Educational Book\u003C/em>, 38, 780-785.\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.softsarcoma-container {\n  max-width: 850px;\n  margin: 32px auto;\n  padding: 24px;\n  background: #f8fafc;\n  border-radius: 18px;\n  font-family: 'Segoe UI', 'PingFang SC', 'Arial', sans-serif;\n  color: #23272e;\n  box-shadow: 0 4px 32px #e5e8ec63;\n}\n.softsarcoma-main-title {\n  color: #2f4554;\n  font-size: 2.3em;\n  text-align: center;\n  font-weight: 700;\n  margin-bottom: 36px;\n  letter-spacing: 1.5px;\n  border-bottom: 2px solid #e9e7f5;\n  padding-bottom: 20px;\n  background: linear-gradient(to right, #e6efff 60%, #fff 100%);\n  border-top-left-radius: 12px;\n  border-top-right-radius: 12px;\n}\n\n.softsarcoma-section {\n  padding: 26px 18px 22px;\n  margin-bottom: 22px;\n  border-radius: 13px;\n  box-sizing: border-box;\n  box-shadow: 0 1px 14px #f1f3f8;\n}\n\n.softsarcoma-subtitle {\n  font-size: 1.27em;\n  font-weight: 600;\n  margin: 0 0 18px 0;\n  letter-spacing: 0.5px;\n  display: flex;\n  align-items: center;\n}\n.softsarcoma-block {\n  border-left: 4px solid #7bbbe6;\n  background: #f9fdff;\n  padding: 17px 14px 14px 14px;\n  border-radius: 8px;\n  margin-bottom: 7px;\n}\n.softsarcoma-list {\n  padding-left: 21px;\n  margin: 0 0 11px 0;\n  line-height: 1.9;\n}\n.softsarcoma-list li {\n  margin-bottom: 0.7em;\n}\n.softsarcoma-tip {\n  margin: 13px 0 4px;\n  padding: 11px 15px;\n  background: #fefee6;\n  color: #9c7724;\n  border-left: 4px solid #ecd065;\n  border-radius: 6px;\n  font-size: 1em;\n  line-height: 1.7;\n}\n.softsarcoma-data {\n  margin-top: 11px;\n  color: #5272a6;\n  font-size: 0.98em;\n  background: #e8f1ff;\n  padding: 7px 10px;\n  border-radius: 5px;\n}\n.softsarcoma-reference {\n  padding: 22px 18px;\n  background: #f6f3fe;\n  border: 1.5px solid #e8e6fa;\n  border-radius: 10px;\n}\n.softsarcoma-ref-list {\n  font-size: 0.96em;\n}\n.softsarcoma-ref-list li {\n  margin-bottom: 9px;\n  border-left: 3px solid #bba5ea;\n  padding-left: 10px;\n  background: #f3f2fc;\n  border-radius: 4px;\n}\n.softsarcoma-bg01 {\n  background: linear-gradient(120deg,#f5fffd 70%,#eafdff 100%);\n}\n.softsarcoma-bg02 {\n  background: linear-gradient(90deg,#fcfefd 72%,#e9fafd 100%);\n}\n.softsarcoma-bg03 {\n  background: linear-gradient(120deg,#fcfdff 50%,#f1f5fc 100%);\n}\n.softsarcoma-bg04 {\n  background: linear-gradient(120deg, #fdf7fd 70%, #fff5fc 100%);\n}\n.softsarcoma-bg05 {\n  background: linear-gradient(90deg,#fcf8fe 65%,#f9f4ff 100%);\n}\n.softsarcoma-bg06 {\n  background: linear-gradient(90deg,#f6fff6 50%,#ebf7ea 100%);\n}\n.softsarcoma-bg07 {\n  background: linear-gradient(120deg,#f7fcff 73%,#ddeffd 100%);\n}\n.softsarcoma-bg08 {\n  background: linear-gradient(120deg,#fff 88%,#faf8fd 100%);\n}\n.softsarcoma-bg09 {\n  background:linear-gradient(120deg,#faf9fc 60%,#eef0fa 100%);\n}\n@media (max-width:600px){\n  .softsarcoma-container {\n    padding: 7px;\n    border-radius: 0;\n    box-shadow: none;\n  }\n  .softsarcoma-main-title {\n    font-size: 1.34em;\n    padding-bottom: 10px;\n  }\n  .softsarcoma-section {\n    padding: 17px 7px 18px;\n    margin-bottom: 13px;\n    border-radius: 8px;\n  }\n  .softsarcoma-block {\n    border-left-width: 2.5px;\n    padding: 8px;\n    border-radius: 6px;\n  }\n  .softsarcoma-tip {\n    padding: 6px 8px;\n    font-size: 0.98em;\n    border-left-width: 2.5px;\n  }\n}\n\u003C/style>","\u003Cdiv class=\"softsarcoma-container\">\n  \u003Ch1 id=\"material_title\" class=\"softsarcoma-main-title\">药品实用指南：",608,"2025-12-14 00:40:32","腺泡状软组织肉瘤, 用药指南, 药物相互作用, 特殊人群用药, 化疗药, 靶向药物, 不良反应, 服用方法","本指南详述腺泡状软组织肉瘤常用药物的安全使用要点，提升患者用药安全性与疗效，关注药物相互作用与特殊人群用药，帮助患者和家属合理用药、有效治疗。","2025-12-27 18:34:02",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]